🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This is a single arm Phase II study, in which 6 cycles of durvalumab with c...
Status
Unknown
Location
Beijing Haidian Hospital
Start Date
2021-09-01
Trial ID
NCT05034133
Treatments Being Tested
The standard of care for muscle-invasive bladder cancer (MIBC) is radical c...
Status
Completed
Location
ICO Badalona
Start Date
2018-11-16
Trial ID
NCT03534492
Treatments Being Tested
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
This is a single arm, multicenter phase II trial for 60 patients with untre...
Status
Terminated
Location
City of Hope
Start Date
2021-01-05
Trial ID
NCT04610684
Treatments Being Tested
This phase II trail will evaluate the efficacy and safety of combining gemc...
Status
Recruiting
Location
Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University
Start Date
2024-10-24
Trial ID
NCT06591650
Treatments Being Tested
Small Cell Lung cancer (SCLC) is a highly aggressive tumor that accounts fo...
Status
Completed
Location
Sixth People's Hospital of Luoyang
Start Date
2021-05-20
Trial ID
NCT04660097
The goal of this research study is to evaluate the safety and tolerability ...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2023-04-21
Trial ID
NCT05701488
Treatments Being Tested
This is a phase 3 study. All subjects are patients with unresectable locall...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2024-10-20
Trial ID
NCT06591520
Treatments Being Tested